Funder
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33.
2. Martinez-Breijo S, Chantada-Abal V, Aller-Rodriguez M, Bohorquez-Cruz M, Sacristan-Lista F, Ponce-Diaz J, et al. Castration resistance mechanisms in prostate cancer. Arch Esp Urol. 2018;71:628–38.
3. Kita Y, Goto T, Akamatsu S, Yamasaki T, Inoue T, Ogawa O, et al. Castration-resistant prostate cancer refractory to second-generation androgen receptor axis-targeted agents: opportunities and challenges. Cancers. 2018;10:345. https://doi.org/10.3390/cancers10100345.
4. Saranyutanon S, Deshmukh SK, Dasgupta S, Pai S, Singh S, Singh AP. Cellular and molecular progression of prostate cancer: models for basic and preclinical research. Cancers. 2020;12:2651. https://doi.org/10.3390/cancers12092651.
5. Sharp A, Coleman I, Yuan W, Sprenger C, Dolling D, Nava Rodrigues D, et al. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer. J Clin Invest. 2019;129:192–208.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献